We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Edwards Lifesciences
EW
$53B
| $37K | ﹤0.01% |
447
-157
| -26% | -$12.3K |
|
627
OneMain Financial
OMF
$7.27B
| $37K | ﹤0.01% |
1,008
+35
| +4% | +$1.41K |
|
628
ResMed
RMD
$31.9B
| $37K | ﹤0.01% |
168
+14
| +9% | +$3.04K |
|
629
Constellation Brands
STZ
$22.8B
| $37K | ﹤0.01% |
162
-70
| -30% | -$15.6K |
|
630
DTE Energy
DTE
$28.5B
| $36K | ﹤0.01% |
325
-373
| -53% | -$41.8K |
|
631
Eaton
ETN
$173B
| $36K | ﹤0.01% |
209
-318
| -60% | -$52.9K |
|
632
Allstate
ALL
$68.2B
| $35K | ﹤0.01% |
318
-223
| -41% | -$28.2K |
|
633
Dollar General
DG
$27B
| $35K | ﹤0.01% |
167
+5
| +3% | +$1.12K |
|
634
Ford
F
$55.8B
| $35K | ﹤0.01% |
2,797
+177
| +7% | +$2.22K |
|
635
Freeport-McMoran
FCX
$98.7B
| $35K | ﹤0.01% |
+861
| New | +$35.8K |
|
|
JHG
636
DELISTED
Janus Henderson
JHG
| $34K | ﹤0.01% |
1,276
-97
| -7% | -$2.58K |
|
637
O'Reilly Automotive
ORLY
$75.3B
| $34K | ﹤0.01% |
600
+285
| +90% | +$15.6K |
|
638
Verisk Analytics
VRSK
$23.6B
| $34K | ﹤0.01% |
175
-10
| -5% | -$1.81K |
|
639
Brown-Forman Class B
BF.B
$12.9B
| $33K | ﹤0.01% |
508
-269
| -35% | -$17.5K |
|
640
Exelon
EXC
$45.8B
| $32K | ﹤0.01% |
770
-868
| -53% | -$36.2K |
|
641
Honeywell
HON
$77B
| $32K | ﹤0.01% |
177
+110
| +164% | +$20.7K |
|
|
PARAA
642
DELISTED
Paramount Global Class A
PARAA
| $31K | ﹤0.01% |
+1,204
| New | +$29.8K |
|
|
PARA
643
DELISTED
Paramount Global Class B
PARA
| $31K | ﹤0.01% |
1,401
-252
| -15% | -$5.41K |
|
644
UWM Holdings
UWMC
$478M
| $31K | ﹤0.01% |
6,379
-2,387
| -27% | -$10.5K |
|
645
Intercontinental Exchange
ICE
$84.5B
| $30K | ﹤0.01% |
292
+165
| +130% | +$17.2K |
|
646
International Flavors & Fragrances
IFF
$21.7B
| $30K | ﹤0.01% |
329
-81
| -20% | -$8.05K |
|
647
Darden Restaurants
DRI
$24.9B
| $29K | ﹤0.01% |
185
-181
| -49% | -$26.8K |
|
648
DaVita
DVA
$11.7B
| $29K | ﹤0.01% |
359
-102
| -22% | -$8.17K |
|
649
Ecolab
ECL
$79.7B
| $29K | ﹤0.01% |
174
+100
| +135% | +$15.6K |
|
650
Lazard
LAZ
$4.16B
| $29K | ﹤0.01% |
864
-25
| -3% | -$922 |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.